The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.23BCNY
633.58M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue (TTM)
657.15MCNY
98.50M · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
-36.87%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Beta
0.3890x
vs all stocks
Updated Oct 23, 2026
52-Week Change
-17.35%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
4.23BCNY
633.58M · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
4.64BCNY
695.50M · vs all stocks (USD)
Updated Oct 23, 2026
Forward P/E
15.92x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Price to Sales (TTM)
6.49x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Price to Book (MRQ)
3.83x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Enterprise to Revenue
7.06x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Enterprise to EBITDA
-118.17x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Gross Margin
38.80%
vs Medical Instruments & Supplies peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 25.92%.Updated Oct 23, 2026
Profit Margin
-36.87%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Operating Margin
-10.66%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Return on Assets (TTM)
-3.58%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Return on Equity (TTM)
-18.44%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Revenue (TTM)
657.15MCNY
98.50M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
1.30CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
-5.90%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Gross Profit (TTM)
170.35MCNY
25.53M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
-39.26MCNY
-5.89M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
-242.31MCNY
-36.32M · vs all stocks (USD)
Updated Oct 23, 2026
Operating Cash Flow (TTM)
38.31MCNY
5.74M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
13.49MCNY
2.02M · vs all stocks (USD)
Updated Oct 23, 2026
5-Year Average Dividend Yield
0.13%
vs all stocks
Updated Oct 23, 2026
Payout Ratio
128.57%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Minority Interest (Equity)
86.13MCNYFY2025 · Dec 31, 2025
Revenue
685.96MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
472.97MCNYFY2025 · Dec 31, 2025
Gross Profit
212.99MCNYFY2025 · Dec 31, 2025
Operating Income
-94.32MCNY
-14.14M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-233.95MCNYFY2025 · Dec 31, 2025
Income Tax Expense
12.87MCNYFY2025 · Dec 31, 2025
Net Income
-246.82MCNYFY2025 · Dec 31, 2025
EBIT
-213.28MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-10.88MCNYFY2025 · Dec 31, 2025
Research & Development
47.92MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
154.54MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
12.97MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.52MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
20.67MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.4700CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.4700CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
522.52MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
522.52MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-246.82MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.24MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-209.91MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-255.71MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
211.80MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-246.82MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
32.44MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-26.92MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
31.40MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-45.80MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-312.66MCNYFY2025 · Dec 31, 2025
Sale of Investments
150.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-208.46MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
634.76MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-447.15MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-19.76MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-34.25MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
133.61MCNYFY2025 · Dec 31, 2025
Shares Outstanding
525.09MSharesUpdated Oct 23, 2026
Float Shares
290.13MSharesUpdated Oct 23, 2026
% Held by Insiders
42.34%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
0.76%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
400.12MCNY
59.97M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
0.7790CNYUpdated Oct 23, 2026
Total Debt (MRQ)
786.16MCNY
117.84M · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
0.6702x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Current Ratio (MRQ)
0.9390x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Book Value per Share (MRQ)
2.12CNYUpdated Oct 23, 2026
Total Assets
2.31BCNY
346.19M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
585.29MCNYFY2025 · Dec 31, 2025
Total Liabilities
1.00BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.72BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
369.67MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
634.42MCNYFY2025 · Dec 31, 2025
Cash
281.97MCNYFY2025 · Dec 31, 2025
Cash Equivalents
13.31MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
295.28MCNYFY2025 · Dec 31, 2025
Accounts Receivable
115.82MCNYFY2025 · Dec 31, 2025
Inventory
112.69MCNYFY2025 · Dec 31, 2025
Accounts Payable
128.49MCNYFY2025 · Dec 31, 2025
Short-term Debt
402.96MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.84MCNYFY2025 · Dec 31, 2025
Long-term Debt
304.10MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
60.11MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
525.09MCNYFY2025 · Dec 31, 2025
Retained Earnings
73.89MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.31BCNY
195.69M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
21.99MCNYFY2025 · Dec 31, 2025
52-Week Low
6.95CNYUpdated Oct 23, 2026
52-Week High
12.36CNYUpdated Oct 23, 2026
52-Week Change
-17.35%
vs all stocks
Updated Oct 23, 2026
Beta
0.3890x
vs all stocks
Updated Oct 23, 2026
50-Day MA
8.15CNYUpdated Oct 23, 2026
200-Day MA
8.83CNYUpdated Oct 23, 2026
Avg 10-Day Volume
13.20MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
15.60MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
-0.4700CNYUpdated Oct 23, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits well below its yearly mean, with net income and assets falling four years.
Reads
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -36.9%, lower than 95% of its Medical Instruments & Supplies peers (median 8.7%)Significant